Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000216648 | SCV000269883 | benign | not specified | 2015-03-11 | criteria provided, single submitter | clinical testing | p.Asn164Asn in exon 11 of TNNT2: This variant is not expected to have clinical s ignificance because it has been identified in 0.33% (56/16512) of South Asian ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs483352833). |
Invitae | RCV000472552 | SCV000554785 | benign | Hypertrophic cardiomyopathy 2; Dilated cardiomyopathy 1D; Cardiomyopathy, familial restrictive, 3 | 2023-09-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000216648 | SCV000730202 | likely benign | not specified | 2017-06-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000771784 | SCV000904468 | benign | Cardiomyopathy | 2018-07-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000771784 | SCV001333851 | benign | Cardiomyopathy | 2017-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345424 | SCV002646425 | likely benign | Cardiovascular phenotype | 2017-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003453050 | SCV004181328 | likely benign | Dilated cardiomyopathy 1D | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453051 | SCV004181330 | likely benign | Cardiomyopathy, familial restrictive, 3 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453049 | SCV004181331 | likely benign | Hypertrophic cardiomyopathy 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Evolutionary and Medical Genetics Laboratory, |
RCV000119342 | SCV000154239 | unknown | Dilated cardiomyopathy 1DD | no assertion criteria provided | not provided | Converted during submission to Uncertain significance. |